Actimed Therapeutics is a clinical stage biopharmaceutical company.
Actimed Therapeutics has raised $6.0M in total funding. The most recent round was Series A. The last funding was announced in August 2023.
Actimed Therapeutics's investors include Mankind Pharma.
Actimed Therapeutics is headquartered in Ascot, United Kingdom.
Actimed Therapeutics is a clinical stage biopharmaceutical company.
Actimed Therapeutics is at the Series A stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Actimed Therapeutics — Funding & Investors." VCBacked, August 22, 2023, https://www.vcbacked.co/company/actimed-therapeutics. Accessed August 14, 2026.
VCBacked. (2023). Actimed Therapeutics — Funding & Investors. Retrieved August 14, 2026, from https://www.vcbacked.co/company/actimed-therapeutics
{{cite web |title=Actimed Therapeutics — Funding & Investors |url=https://www.vcbacked.co/company/actimed-therapeutics |website=VCBacked |access-date=August 14, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated